comparemela.com

Latest Breaking News On - University hospital essen - Page 20 : comparemela.com

Theragnostics Announces a research collaboration with Essen University Hospital to study THG-008 for Oncology PET Imaging

Share this article Share this article LONDON, Feb. 17, 2021 /PRNewswire/  Theragnostics, which is developing molecular radiotherapy for imaging and treating a broad range of cancers, today announces a research collaboration with Essen University Hospital to examine Theragnostics investigational agent THG-008 for PET imaging in a range of cancers. The research is due to start in February 2021 and will be led by Dr. Michael Nader, head of radiochemistry and part of the Clinic for Nuclear Medicine at Universitätsklinikum Essen (University Hospital Essen), in Germany. THG-008 is a novel fluorine-18 radiolabelled PARP inhibitor ( 18F-PARPi) which has a number of applications relevant to imaging cancer. A Phase 1 clinical study for THG-008 in head and neck squamous cell carcinoma (HNSCC) completed recruitment in May 2019. Data published in a peer-reviewed publication confirmed imaging of head and neck cancer with 

Silent Mutation Linked to Worse Kidney Cancer Outcome | The Scientist Magazine®

For decades, researchers have viewed synonymous mutations as inconsequential quirks of the genome. Due to the way the genetic code is set up where multiple three-base-pair codons can encode the same amino acid mutations can arise that don’t change a protein’s amino acid sequence. Scientists have largely dismissed these anomalies as harmless oddities. But like other historically underappreciated aspects of the genome, scientists are realizing that many “silent” mutations might not be so silent after all. Research suggests they’re often subject to selective pressure and could play a role in cancer, autism, and schizophrenia. A study published online last week (February 12) in

Activ Surgical Welcomes Prof Dr Rainer Kimmig to its European Advisory Board

Activ Surgical Welcomes Prof. Dr. Rainer Kimmig to its European Advisory Board BOSTON and ESSEN, Germany, Feb. 16, 2021 /PRNewswire/ Activ Surgical, a digital surgery pioneer, today announced the appointment of Prof. Dr. Rainer Kimmig to its European Advisory Board. Prof. Dr. Kimmig currently serves as the department head of Gynecology and Obstetrics at the West German Cancer Center at the University Hospital Essen, Germany, as well as the Chair and full professor at the University of Duisburg-Essen. In his role on Activ Surgical s European Advisory Board, Prof. Dr. Kimmig will collaborate with his peers from leading hospital systems across the European Union (EU) to advise on the company s go-to-market efforts for its products, including

Μια «Πράξη αγάπης» βοήθησε στη θεραπεία του νεαρού Αλέξανδρου

Μια «Πράξη αγάπης» βοήθησε στη θεραπεία του νεαρού Αλέξανδρου
gazzetta.gr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gazzetta.gr Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.